Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

计划入组 32 人 · 首次发布于 2010 年 6 月 11 日

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

计划入组 270 人 · 首次发布于 2015 年 1 月 9 日

Avian Influenza Studies In Lebanon

计划入组 250 人 · 首次发布于 2010 年 4 月 20 日

H5N1 avian influenza vaccine

H7N9 avian influenza vaccine

H5N1 avian influenza vaccine (PowderMed)

Research Institute of Influenza

Russia

Sernova Corp

Canada

Hualan Biological Vaccine Inc.

China

Boehringer Ingelheim Introduces Novel Trivalent Vaccine Combining H5 Avian Flu Protection with Core Poultry Immunizations

European Medicines Agency Recommends Approval for Two Boehringer Ingelheim Avian Flu Vaccines

HHS Quietly Advances Marburg and Sudan Ebolavirus Vaccine Development Despite Kennedy's Vaccine Skepticism